DCBLD2 and cancer: Elevated expression of DCBLD2 was significantly associated with decreased OS time in various cancers including PDAC (Raman et al., 2018), colorectal cancer (Martinez-Romero et al., 2018), hypopharyngeal squamous cell carcinoma (Fukumoto et al., 2014) and melanoma (Osella-Abate et al., 2012).